Circulating neuropeptide Y in humans: Relation to changes in catecholamine levels and changes in hemodynamics

Neuropeptides

Volumn 30, Issue 2, 1996, Pages 159-165

  Hauser, G J ^a   Danchak, M R ^b   Colvin, M P ^a   Hopkins, R A ^b   Wocial, B ^d   Myers, A K ^c   Zukowska Grojec, Z ^c  

^a Children's Medical Center   (United States)

^b GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c GEORGETOWN UNIVERSITY   (United States)

^d MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; NEUROPEPTIDE Y; NORADRENALIN;

ADULT; ARTICLE; CATECHOLAMINE BLOOD LEVEL; CLINICAL ARTICLE; EXERCISE; FEMALE; HEART HEMODYNAMICS; HEART INDEX; HEART STROKE VOLUME; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOREACTIVITY; MALE; MEAN ARTERIAL PRESSURE; PEPTIDE ANALYSIS; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; SURGICAL STRESS; VASCULAR RESISTANCE;

EID: 0029980954     PISSN: 01434179     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0143-4179(96)90083-9     Document Type: Article

References (24)

1. Zukowska-Grojec Z, Wahlestedt C. Origin and actions of neuropeptide Y in the cardiovascular system. In: Colmers W F, Wahlestedt C, eds. The biology of neuropeptide Y and related peptides. Totowa: Humana Press, 1993: 315-388.
2. Zukowska-Grojec Z, Marks E S, Haass M. Neuropeptide Y is a potent vasoconstrictor and a cardiodepressant in rats. Am J Physiol 1987; 253: H1234-H1239.
3. Clarke J G, Kerwin R, Larkin S et al. Coronary artery infusion of neuropeptide Y in patients with angina pectoris. Lancet 1987; 1: 1057-1059.
4. Maisel A S, Scott N A, Motulsky H J et al. Elevation of plasma neuropeptide Y levels in congestive heart failure. Am J Med 1989; 86: 43-48.
5. Morris MJ, Elliott J M, Cain M D et al. Plasma neuropeptide Y levels in patients undergoing exercise tests for the investigation of chest pain. Clin Exp Pharm Physiol 1986; 13: 437-440.
6. Hulting J, Sollevi A, Ullman B et al. Plasma neuropeptide Y on admission to a coronary care unit: raised levels in patients with left heart failure. Cardiovasc Res 1990; 24: 102-108.
7. Kim Y D, Jones M, Hanowell, S T et al. Changes in peripheral vascular and cardiac sympathetic activity before and after coronary artery bypass surgery: interrelationship with hemodynamic alterations. Am Heart J 1981; 102: 972-979.
8. Franco-Cereceda A, Owall A, Settergren G et al. Release of neuropeptide Y and noradrenaline from the human heart after aortic occlusion during coronary artery surgery. Cardiovasc Res 1990; 24: 242-246.
9. Zukowska-Grojec Z, Konarska M, McCarty R. Differential plasma catecholamine and neuropeptide Y responses to acute stress in rats. Life Sci 1987; 42: 1615-1624.
10. Zukowska-Grojec Z, Haass M, Bayorh M A. Neuropeptide Y and peptide YY mediate non-adrenergic vasoconstriction and modulate sympathetic responses in rats. Regul Pept 1986; 15: 99-110.
11. Myers A K, Farhat M Y, Vaz C A et al. Release of immunoreactive-neuropeptide Y by rat platelets. Biochem Biophys Res Commun 1988; 155: 118-122.
12. Myers A K, Torres-Duarte A P, Zukowska-Grojec Z. Immunoreactive neuropeptide Y (NPY) in plasma and platelets of rat and mouse strains and human volunteers. Regul Pept 1993; 47: 239-245.
13. Haass M, Hock M, Richardt G et al. Neuropeptide Y differentiates between exocytotic and non-exocytotic noradrenaline release in guinea-pig heart. Naunyn Schmiedebergs Arch Pharmacol 1989; 340: 509-515.
14. Derchi G, Dupuis J, DeChamplain J et al. Paradoxical decrease in circulating neuropeptide-Y like immunoreactivity during mild orthostatic stress in subjects with and without congestive heart failure. Eur Heart J 1993; 14: 34-39.
15. Kaijser L, Pernow J, Berglund B et al. Neuropeptide Y is released together with noradrenaline from the human heart during exercise and hypoxia. Clin Physiol 1990; 10: 179-188.
16. Takahashi K, Mouri T, Murakami O et al. Increases of neuropeptide Y-like immunoreactivity in plasma during insulin-induced hypoglycemia in man. Peptides 1988; 9: 433-435.
17. Zukowska-Grojec Z, Shen G H, Deka-Starosta A et al. Neuronal, adrenomedullary and platelet-derived neuropeptide Y responses to stress in rats. In: Kvetnansky R, McCarty R, Axelrod J, eds. Stress: neuroendocrine and molecular approaches. New York: Gordon and Breach, 1992: 197-209.
18. Kalter R D, Saul C M, Wetstein L et al. Cardiopulmonary bypass. Associated hemostatic abnormalities. J Thorac Cardiovasc Surg 1992; 77: 427-435.
19. Ericsson A, Hemsen A, Lundberg J M et al. Detection of neuropeptide Y-like immunoreactivity and messenger RNA in rat platelets: the effects of vinblastine, reserpine and dexamethasone on NPY expression in blood cells. Exp Cell Res 1991; 192: 604-611.
20. Hoar P F, Stone J G, Faltas A N et al. Hemodynamic and adrenergic responses to anesthesia and operation for myocardial revascularization. J Thorac Cardiovasc Surg 1990; 80: 242-248.
21. Lundberg J M, Anggard A, Theodeorsson-Norheim E et al. Guanethidine-sensitive release of neuropeptide Y-like immunoreactivity in the cat spleen by sympathetic nerve stimulation. Neurosci Lett 1984; 52: 175-180.
22. Pernow J, Lundberg J M, Kaijser L. Vasoconstrictor effects in vivo and plasma disappearance rate of neuropeptide Y in man. Life Sci 1987; 40: 47-54.
23. Eckberg D L, Rea R F, Andersson O K et al. Baroreflex modulation of sympathetic activity and sympathetic neurotransmitters in humans. Acta Physiol Scand 1988; 133: 221-231.
24. Dubois-Rande J L, Comoy E, Merlet P et al. Relationship among neuropeptide Y, catecholamines and haemodynamics in congestive heart failure. Eur Heart J 1992; 13: 1233-1238.